2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Orlistat: new trials by email Literature Review of Orlistat trials Research Report on Orlistat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms 120 mg orlistat, 60 mg orlistat, orlistat experimental dose - Overweight | Phase 1 | Completed | GlaxoSmithKline | 48 | 2009-02-01 | 2013-01-28 |
| Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome Xenical, Pionorm, Diroton, Diltiazem, Atorvastatin, "Analimentary detoxication" - Metabolic Syndrome | Phase 1 / Phase 2 | Completed | Nazarbayev University | 351 | 2003-01-01 | 2015-11-30 |
Overweight (2) · Diabetes Mellitus (1) · Hypertension (1) · Metabolic Syndrome (1)
GlaxoSmithKline (1) · Nazarbayev University (1)
Kazakhstan (1) · United Kingdom (1)
Tabynbayev Nariman, Professor (1)